OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 25, 2021
A recent study examined how insulin levels and body mass index may have ties to mental health concerns.
January 22, 2021
Investigators compared outcomes among patients with COVID-19 and hypertension through modifying blood pressure medication use.
January 19, 2021
Over-the-counter product selection for patients with diabetes.
January 08, 2021
The agency granted priority review to dapagliflozin (Farxiga; AstraZeneca) for the treatment of new or worsening chronic kidney disease in adults with and without type 2 diabetes.
December 28, 2020
The Drug Topics® team rounded up some of our top-read articles from the last year.
November 26, 2020
A study to be presented at the annual meeting of the Radiological Society of North America reported that COVID-19 patients with diabetes and hypertension may have a higher risk for neurologic complications.
November 09, 2020
What pharmacists need to know about helping patients navigate changing landscape.
November 05, 2020
Researchers reported that patients who received finerenone had a lower risk of kidney failure or death from renal causes.
October 27, 2020
A subgroup analysis of the DAPA-CKD phase 3 trial reported on the continued benefit of dapagliflozin in patients with chronic kidney disease, regardless of underlying cause.
October 09, 2020
Patients now have a variety of options to help them lose weight, and pharmacists can offer a variety of specialized services to support their patients’ needs.